China To Step Up Supervision Of APIs And Drug Excipients – PDA-FDA Supply Chain Conference
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA is planning to launch a drug master file system to establish better controls for active pharmaceutical ingredients and drug excipients
You may also be interested in...
China One Step Closer To Global Standards For Drug Quality With Rollout Of New GMP Guidelines
SHANGHAI - China's State FDA recently issued a note to provincial FDA offices to require pharma companies and active pharmaceutical ingredient producers to file a Common Technical Document when they submit manufacturing applications as an effort to improve drug quality and research and development work in China
China One Step Closer To Global Standards For Drug Quality With Rollout Of New GMP Guidelines
SHANGHAI - China's State FDA recently issued a note to provincial FDA offices to require pharma companies and active pharmaceutical ingredient producers to file a Common Technical Document when they submit manufacturing applications as an effort to improve drug quality and research and development work in China
China Adds CTD and DMF Filing Requirements to Enhance Drug Quality
SHANGHAI – China’s State FDA recently issued a note to provincial FDA offices to require pharma companies and active pharmaceutical ingredient producers to file a Common Technical Document when they submit manufacturing applications as an effort to improve drug quality and research and development work in China.